Combination Therapy of Olmesartan and Azelnidipine Inhibits Sympathetic Activity Associated with Reducing Oxidative Stress in the Brain of Hypertensive Rats-Reference-Cited by-同舟云学术

Combination Therapy of Olmesartan and Azelnidipine Inhibits Sympathetic Activity Associated with Reducing Oxidative Stress in the Brain of Hypertensive Rats

Published:2012-04-03 Issue:6 Volume:34 Page:456-462
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Shinohara Keisuke,Hirooka Yoshitaka,Ogawa Kiyohiro,Kishi Takuya,Yasukawa Keiji,Utsumi Hideo,Sunagawa Kenji

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10641963.2012.666603

Reference43 articles.

1. 2007 Guidelines for the Management of Arterial Hypertension

2. Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

3. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients

4. Sympathetic Neural Activity in Hypertension and Related Diseases

5. A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of renal denervation on blood pressure, cardiac hypertrophy, and sympathetic activity during the established phase of hypertension in spontaneously hypertensive rats;Hypertension Research;2024-02-09

2. Clarification of hypertension mechanisms provided by the research of central circulatory regulation;Hypertension Research;2023-06-05

3. Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease;Clinical and Experimental Hypertension;2018-04-25

4. Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats;Journal of Neuroscience Research;2014-05-20

5. Moxonidine-induced central sympathoinhibition improves prognosis in rats with hypertensive heart failure;Journal of Hypertension;2013-11